Journal
FOOD CHEMISTRY
Volume 119, Issue 4, Pages 1571-1577Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.foodchem.2009.09.044
Keywords
Soybean; beta-Conglycinin; Bioactive peptides; Fatty acid synthase; Adipogenesis
Funding
- Monsanto Company
- European Commission
Ask authors/readers for more resources
The objective was to assess the effect of protein hydrolysates of beta-conglycinin enriched soybean on fatty acid synthase (FAS) activity and adipogenic response of human adipocytes in vitro. The results showed that genotypic changes in soybean protein Subunits produced peptide profiles that led to inhibition of FAS and lipid accumulation in vitro. FAS inhibitory potency (IC50) Of SOY protein hydrolysates (SPH) ranged from 50 to 175 IN, while lipid inhibition from 15.6% to 45.9%. Protein hydrolysate C2H from a soybean containing the highest total beta-conglycinin (46.9%) showed the most potent inhibitory effect on in vitro adipogenesis (46%) and FAS (IC50 = 50 mu M). C2H was composed of dominant peptides from fragments f(85-112) and f(131-132) of beta-conglycinin alpha subunit. Smaller peptides identified as fragments f(330-342) and f(329-342) of alpha' subunit were also found. In conclusion, soybean genotypes enriched in beta-conglycinin alpha and alpha' subunits are suitable sources of active peptides that inhibit FAS activity and lipid accumulation. (C) 2009 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available